125 results on '"Csajka, Chantal"'
Search Results
2. A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial
3. Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland
4. The TuberXpert project protocol: Towards a Clinical Decision Support System for therapeutic anti-tuberculosis medical drugs monitoring in Tanzania
5. Automated Detection of Adverse Drug Events from Older Patients’ Electronic Medical Records Using Text Mining
6. Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study
7. Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy
8. Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project
9. Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging
10. Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)
11. From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
12. Dementia prevention in memory clinics: recommendations from the European task force for brain health services
13. Erratum to ‘Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians’ The American Journal of Medicine, Volume 134 (2021), Issue 8, 939-942
14. Pratique de la pharmacie clinique en Suisse romande
15. Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study
16. Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
17. Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
18. Impact of Pharmaceutical Interventions with STOPP/START and PIM-Check in Older Hospitalized Patients: A Randomized Controlled Trial
19. Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
20. Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis
21. Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP)
22. Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients – A cohort study comparing 19 anticholinergic burden scales
23. Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
24. Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation
25. Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland
26. Phagothérapie pour traiter les infections respiratoires
27. High anticholinergic burden at admission associated with in‐hospital mortality in older patients: A comparison of 19 different anticholinergic burden scales
28. Parametric and Nonparametric Methods in Population Pharmacokinetics: Experts’ Discussion on Use, Strengths, and Limitations
29. Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation
30. Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6
31. Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians
32. Cross-cultural adaptation and psychometric validation of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire in French
33. Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2
34. Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data
35. Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data (Preprint)
36. Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review
37. Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration
38. Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs
39. Revised Patients' Attitudes Towards Deprescribing Questionnaire--French Version
40. Impact of Pharmaceutical Interventions in Hospitalized Patients: A Comparative Study Between Clinical Pharmacists and an Explicit Criteria-Based Tool
41. Therapeutic Drug Monitoring of Targeted Anticancer Therapy. Tyrosine Kinase Inhibitors and Selective Estrogen Receptor Modulators: A Clinical Pharmacology Laboratory Perspective
42. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review
43. A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk
44. Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
45. Optimisation of vancomycin exposure in neonates based on the best level of evidence
46. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HI
47. The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
48. Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review
49. Enquête « RTO-COVID-19 » : nos soins, nos actions, leurs effets
50. Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.